Impact of coronary artery disease and revascularization on outcomes of transcatheter aortic valve replacement for severe aortic stenosis

IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Yoshiyuki Yamashita , Serge Sicouri , Massimo Baudo , Aleksander Dokollari , Roberto Rodriguez , Eric M. Gnall , Paul M. Coady , Harish Jarrett , Sandra V. Abramson , Katie M. Hawthorne , Scott M. Goldman , William A. Gray , Basel Ramlawi
{"title":"Impact of coronary artery disease and revascularization on outcomes of transcatheter aortic valve replacement for severe aortic stenosis","authors":"Yoshiyuki Yamashita ,&nbsp;Serge Sicouri ,&nbsp;Massimo Baudo ,&nbsp;Aleksander Dokollari ,&nbsp;Roberto Rodriguez ,&nbsp;Eric M. Gnall ,&nbsp;Paul M. Coady ,&nbsp;Harish Jarrett ,&nbsp;Sandra V. Abramson ,&nbsp;Katie M. Hawthorne ,&nbsp;Scott M. Goldman ,&nbsp;William A. Gray ,&nbsp;Basel Ramlawi","doi":"10.1016/j.carrev.2024.05.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background/purpose</h3><div><span>To evaluate the impact of coronary artery disease (CAD), percutaneous coronary intervention (PCI), and coronary lesion complexity on outcomes of </span>transcatheter aortic valve replacement<span> (TAVR) for aortic stenosis.</span></div></div><div><h3>Methods/materials</h3><div><span><span>This retrospective study included 1042 patients divided into two groups by the presence or absence of CAD (SYNTAX score 0, no history of revascularization). </span>Propensity score matching was used to compare the two groups. The effect of PCI, </span>SYNTAX score, and residual SYNTAX score was also analyzed.</div></div><div><h3>Results</h3><div>The median age of the cohort was 82 years, and 641 patients had CAD. After propensity score matching, 346 pairs were analyzed. During 5 years of follow-up (median: 25, range 0–72 months), the rate of coronary intervention was significantly higher in CAD patients (<em>p</em><span> = 0.018). However, all-cause mortality, composite of all-cause mortality, stroke, and coronary intervention, and overt bleeding defined by VARC-3 were comparable. After stratification, in patients with creatinine ≥1.5 mg/dl, CAD was associated with a worse composite outcome (</span><em>p</em> = 0.016). Neither PCI nor SYNTAX score was associated with all-cause mortality in CAD patients. Similarly, residual SYNTAX score showed no association with mortality in patients undergoing PCI (all <em>p</em> values &gt;0.7). PCI did not reach a significant difference in overt bleeding in CAD patients (adjusted <em>p</em> = 0.06).</div></div><div><h3>Conclusions</h3><div>Despite a higher incidence of coronary interventions, major clinical outcomes were similar between patients with and without CAD after TAVR. In patients with chronic kidney disease, CAD may be associated with an adverse composite outcome. Neither PCI nor SYNTAX/residual SYNTAX score influenced all-cause mortality.</div></div>","PeriodicalId":47657,"journal":{"name":"Cardiovascular Revascularization Medicine","volume":"68 ","pages":"Pages 8-14"},"PeriodicalIF":1.6000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Revascularization Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1553838924004615","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background/purpose

To evaluate the impact of coronary artery disease (CAD), percutaneous coronary intervention (PCI), and coronary lesion complexity on outcomes of transcatheter aortic valve replacement (TAVR) for aortic stenosis.

Methods/materials

This retrospective study included 1042 patients divided into two groups by the presence or absence of CAD (SYNTAX score 0, no history of revascularization). Propensity score matching was used to compare the two groups. The effect of PCI, SYNTAX score, and residual SYNTAX score was also analyzed.

Results

The median age of the cohort was 82 years, and 641 patients had CAD. After propensity score matching, 346 pairs were analyzed. During 5 years of follow-up (median: 25, range 0–72 months), the rate of coronary intervention was significantly higher in CAD patients (p = 0.018). However, all-cause mortality, composite of all-cause mortality, stroke, and coronary intervention, and overt bleeding defined by VARC-3 were comparable. After stratification, in patients with creatinine ≥1.5 mg/dl, CAD was associated with a worse composite outcome (p = 0.016). Neither PCI nor SYNTAX score was associated with all-cause mortality in CAD patients. Similarly, residual SYNTAX score showed no association with mortality in patients undergoing PCI (all p values >0.7). PCI did not reach a significant difference in overt bleeding in CAD patients (adjusted p = 0.06).

Conclusions

Despite a higher incidence of coronary interventions, major clinical outcomes were similar between patients with and without CAD after TAVR. In patients with chronic kidney disease, CAD may be associated with an adverse composite outcome. Neither PCI nor SYNTAX/residual SYNTAX score influenced all-cause mortality.
冠状动脉疾病和血管重建对经导管主动脉瓣置换术治疗重度主动脉瓣狭窄疗效的影响。
背景/目的:评估冠状动脉疾病(CAD)、经皮冠状动脉介入治疗(PCI)和冠状动脉病变复杂性对主动脉瓣狭窄经导管主动脉瓣置换术(TAVR)疗效的影响:这项回顾性研究纳入了 1042 名患者,按照是否存在 CAD(SYNTAX 评分 0,无血管再通史)分为两组。采用倾向评分匹配法对两组患者进行比较。同时还分析了PCI、SYNTAX评分和残余SYNTAX评分的影响:结果:组群的中位年龄为 82 岁,641 名患者患有 CAD。经过倾向评分匹配后,对 346 对患者进行了分析。在 5 年的随访期间(中位数:25,范围 0-72 个月),CAD 患者的冠状动脉介入率明显更高(p = 0.018)。然而,全因死亡率、全因死亡率、中风和冠状动脉介入治疗的复合死亡率以及 VARC-3 定义的明显出血率却相当。经过分层后,在肌酐≥1.5 mg/dl 的患者中,CAD 与较差的综合预后相关(p = 0.016)。PCI和SYNTAX评分均与CAD患者的全因死亡率无关。同样,残余 SYNTAX 评分与接受 PCI 患者的死亡率也没有关系(所有 p 值均大于 0.7)。PCI与CAD患者的明显出血没有明显差异(调整后P = 0.06):结论:尽管冠状动脉介入治疗的发生率较高,但TAVR术后有CAD和无CAD患者的主要临床结果相似。在慢性肾脏病患者中,CAD可能与不良的综合结果有关。PCI和SYNTAX/剩余SYNTAX评分均不影响全因死亡率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cardiovascular Revascularization Medicine
Cardiovascular Revascularization Medicine CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
3.30
自引率
5.90%
发文量
687
审稿时长
36 days
期刊介绍: Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine. Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management, and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信